Rapid Nutrition（0RNS）株式概要ナチュラルヘルスケア企業であるラピッドニュートリションPLCは、科学的根拠に基づいた健康とウェルネス製品を開発し、世界中で販売している。 詳細0RNS ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性6/6配当金0/6リスク分析UK市場と比較して、過去 3 か月間の株価の変動が非常に大きい意味のある時価総額がありません ( €3M )収益が 100 万ドル未満 ( A$194K )すべてのリスクチェックを見る0RNS Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW489,752 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA489,752 investors already sharing narrativesYour Fair Value€Current Price€6.607.9k% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-10m5m2016201920222025202620282031Revenue AU$46.9kEarnings AU$4.9kAdvancedSet Fair ValueView all narrativesRapid Nutrition PLC 競合他社Chill Brands GroupSymbol: LSE:CHLLMarket cap: UK£1.2mPotter & MooreSymbol: AIM:PAMMarket cap: UK£16.1mRevolution Beauty GroupSymbol: AIM:REVBMarket cap: UK£39.1mVenture Life GroupSymbol: AIM:VLGMarket cap: UK£84.7m価格と性能株価の高値、安値、推移の概要Rapid Nutrition過去の株価現在の株価€6.6052週高値€11.9652週安値€2.40ベータ-0.421ヶ月の変化6.97%3ヶ月変化-44.82%1年変化0%3年間の変化-99.18%5年間の変化-99.90%IPOからの変化-99.90%最新ニュースお知らせ • 7hRapid Nutrition Rolls Out Premium Nutrition Pantry Across Healthshop+ Wellness Hub Network And Online ChannelsRapid Nutrition announced the expansion of its owned-brand portfolio through the rollout of its new Premium Nutrition Pantry across the HealthShop+ wellness hub network and online channels. The initial rollout of the Premium Nutrition Pantry will comprise up to 100 premium wholefood products featuring sustainably sourced, minimally processed ingredients designed to complement the Company's evidence-based nutrition philosophy and support healthier everyday living. The launch represents an important milestone in Rapid Nutrition's strategy to expand higher-margin owned-brand sales while leveraging its vertically integrated wellness platform to accelerate product innovation, improve commercial agility and support long-term growth. Historically, this category has generated annual sales approaching AUD 1 million across the Company's wellness hubs. Management believes introducing the Premium Nutrition Pantry under the Rapid Nutrition brand provides an opportunity to build upon this established consumer demand while strengthening brand ownership, increasing margin potential and supporting long-term shareholder value. The acquisition of the HealthShop+ wellness hub network has also provided Rapid Nutrition with access to valuable real-time customer purchasing data and category insights across multiple wellness hubs. As part of its broader digital transformation strategy, the Company is progressively incorporating AI-driven analytics to better understand customer purchasing behaviour, emerging wellness trends and evolving category demand. These insights are expected to support faster identification of high-potential product opportunities, optimise merchandising decisions and accelerate the expansion of both the Premium Nutrition Pantry and the Company's broader owned-brand portfolio across its wellness hubs and online channels. The launch of the Premium Nutrition Pantry represents the first commercial application of this strategy, demonstrating how proprietary customer data, AI-driven analytics and Rapid Nutrition's vertically integrated wellness platform can be combined to identify emerging category opportunities, accelerate product expansion and strengthen higher-margin owned-brand sales.お知らせ • Jun 02Rapid Nutrition Expands Agentic AI Integration Across Consumer Wellness EcosystemRapid Nutrition PLC has progressively expanded the rollout of its technology-enabled engagement platform across investor communications, consumer wellness interactions and broader digital operations as part of its strategy to build a scalable HealthTech ecosystem at the intersection of nutrition, technology and consumer behaviour. Following the initial deployment across investor communications, Rapid Nutrition has observed improved accessibility and responsiveness, with investor enquiries increasingly being addressed in near real-time across multiple time zones. The Company has since expanded the platform across elements of its consumer ecosystem, including the Company’s flagship SystemLS brand, where early-stage engagement trends indicate increasing interaction with product, wellness and lifestyle-aligned content tailored to individual user interests and behaviours. Rapid Nutrition believes the application of artificial intelligence and agentic capabilities enables a transition from static information delivery toward more responsive, real-time and personalized engagement across both investor and consumer channels. The platform has been developed using Company materials and operational frameworks and continues to be refined by Rapid Nutrition’s experienced team to ensure alignment with the Company’s products, communication standards and broader wellness ecosystem.お知らせ • May 13Rapid Nutrition plc Expands AI-Powered Agentic Platform to Consumer EcosystemRapid Nutrition PLC announced the expansion of its technology platform to its consumer-facing ecosystem, following a successful rollout within its investor communications infrastructure. The Company is extending these capabilities across its flagship SystemLS brand, enabling a more responsive and personalized approach to consumer health and wellness engagement. The platform delivers structured, on-demand guidance across nutrition, products, and lifestyle — available 24/7 in a private, confidential environment. As consumer expectations increasingly flavor personalized health solutions, the system is designed to translate product and nutritional information into practical, everyday guidance aligned to individual habits and routines. Trained on Company materials and informed by Rapid Nutrition’s experienced team, the platform ensures all responses reflect the Company’s product philosophy, nutritional methodologies, and established wellness programs. The system is designed to complement, not replace, professional human interaction — extending access to practitioner-informed guidance while maintaining alignment with the Company’s personalised nutrition approach. It supports consumer education only and does not constitute professional medical advice. This expansion represents a continued step in Rapid Nutrition’s strategy to deploy advanced technologies — including artificial intelligence and agentic capabilities — across both its corporate and consumer operations, driving deeper and more consistent engagement with long-term wellness programs.Board Change • Apr 30Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. 1 independent director (2 non-independent directors). Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Apr 22Rapid Nutrition PLC (ENXTPA:ALRPD) agreed to acquire Health and wellness retail locations in Australia.Rapid Nutrition PLC (ENXTPA:ALRPD) agreed to acquire Health and wellness retail locations in Australia on April 20, 2026. The transaction is subject to consummation of due diligence investigation and final documentation.Board Change • Feb 06Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. 1 independent director (2 non-independent directors). Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.最新情報をもっと見るRecent updatesお知らせ • 7hRapid Nutrition Rolls Out Premium Nutrition Pantry Across Healthshop+ Wellness Hub Network And Online ChannelsRapid Nutrition announced the expansion of its owned-brand portfolio through the rollout of its new Premium Nutrition Pantry across the HealthShop+ wellness hub network and online channels. The initial rollout of the Premium Nutrition Pantry will comprise up to 100 premium wholefood products featuring sustainably sourced, minimally processed ingredients designed to complement the Company's evidence-based nutrition philosophy and support healthier everyday living. The launch represents an important milestone in Rapid Nutrition's strategy to expand higher-margin owned-brand sales while leveraging its vertically integrated wellness platform to accelerate product innovation, improve commercial agility and support long-term growth. Historically, this category has generated annual sales approaching AUD 1 million across the Company's wellness hubs. Management believes introducing the Premium Nutrition Pantry under the Rapid Nutrition brand provides an opportunity to build upon this established consumer demand while strengthening brand ownership, increasing margin potential and supporting long-term shareholder value. The acquisition of the HealthShop+ wellness hub network has also provided Rapid Nutrition with access to valuable real-time customer purchasing data and category insights across multiple wellness hubs. As part of its broader digital transformation strategy, the Company is progressively incorporating AI-driven analytics to better understand customer purchasing behaviour, emerging wellness trends and evolving category demand. These insights are expected to support faster identification of high-potential product opportunities, optimise merchandising decisions and accelerate the expansion of both the Premium Nutrition Pantry and the Company's broader owned-brand portfolio across its wellness hubs and online channels. The launch of the Premium Nutrition Pantry represents the first commercial application of this strategy, demonstrating how proprietary customer data, AI-driven analytics and Rapid Nutrition's vertically integrated wellness platform can be combined to identify emerging category opportunities, accelerate product expansion and strengthen higher-margin owned-brand sales.お知らせ • Jun 02Rapid Nutrition Expands Agentic AI Integration Across Consumer Wellness EcosystemRapid Nutrition PLC has progressively expanded the rollout of its technology-enabled engagement platform across investor communications, consumer wellness interactions and broader digital operations as part of its strategy to build a scalable HealthTech ecosystem at the intersection of nutrition, technology and consumer behaviour. Following the initial deployment across investor communications, Rapid Nutrition has observed improved accessibility and responsiveness, with investor enquiries increasingly being addressed in near real-time across multiple time zones. The Company has since expanded the platform across elements of its consumer ecosystem, including the Company’s flagship SystemLS brand, where early-stage engagement trends indicate increasing interaction with product, wellness and lifestyle-aligned content tailored to individual user interests and behaviours. Rapid Nutrition believes the application of artificial intelligence and agentic capabilities enables a transition from static information delivery toward more responsive, real-time and personalized engagement across both investor and consumer channels. The platform has been developed using Company materials and operational frameworks and continues to be refined by Rapid Nutrition’s experienced team to ensure alignment with the Company’s products, communication standards and broader wellness ecosystem.お知らせ • May 13Rapid Nutrition plc Expands AI-Powered Agentic Platform to Consumer EcosystemRapid Nutrition PLC announced the expansion of its technology platform to its consumer-facing ecosystem, following a successful rollout within its investor communications infrastructure. The Company is extending these capabilities across its flagship SystemLS brand, enabling a more responsive and personalized approach to consumer health and wellness engagement. The platform delivers structured, on-demand guidance across nutrition, products, and lifestyle — available 24/7 in a private, confidential environment. As consumer expectations increasingly flavor personalized health solutions, the system is designed to translate product and nutritional information into practical, everyday guidance aligned to individual habits and routines. Trained on Company materials and informed by Rapid Nutrition’s experienced team, the platform ensures all responses reflect the Company’s product philosophy, nutritional methodologies, and established wellness programs. The system is designed to complement, not replace, professional human interaction — extending access to practitioner-informed guidance while maintaining alignment with the Company’s personalised nutrition approach. It supports consumer education only and does not constitute professional medical advice. This expansion represents a continued step in Rapid Nutrition’s strategy to deploy advanced technologies — including artificial intelligence and agentic capabilities — across both its corporate and consumer operations, driving deeper and more consistent engagement with long-term wellness programs.Board Change • Apr 30Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. 1 independent director (2 non-independent directors). Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Apr 22Rapid Nutrition PLC (ENXTPA:ALRPD) agreed to acquire Health and wellness retail locations in Australia.Rapid Nutrition PLC (ENXTPA:ALRPD) agreed to acquire Health and wellness retail locations in Australia on April 20, 2026. The transaction is subject to consummation of due diligence investigation and final documentation.Board Change • Feb 06Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. 1 independent director (2 non-independent directors). Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Buy Or Sell Opportunity • Jan 22Now 35,962% overvalued after recent price riseOver the last 90 days, the stock has risen 118,321% to €4.50. The fair value is estimated to be €0.012, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 41% over the last 3 years. Meanwhile, the company became loss making.お知らせ • Jan 05Rapid Nutrition PLC announced that it has received €5 million in fundingRapid Nutrition PLC announced a private placement of common shares for gross proceeds of €5 million on January 5, 2026.Reported Earnings • Oct 29First half 2025 earnings released: EPS: AU$0 (vs AU$0 in 1H 2024)First half 2025 results: EPS: AU$0 (in line with 1H 2024). Revenue: AU$113.1k (down 59% from 1H 2024). Net loss: AU$1.65m (loss narrowed 17% from 1H 2024). Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 2.7% growth forecast for the Personal Products industry in the United Kingdom.New Risk • Oct 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 17% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 7x increase in shares outstanding). Revenue is less than US$1m (AU$917k revenue, or US$594k). Market cap is less than US$10m (€2.14m market cap, or US$2.50m). Minor Risks Latest financial reports are more than 6 months old (reported December 2024 fiscal period end). Share price has been volatile over the past 3 months (10% average weekly change).Buy Or Sell Opportunity • Jun 20Now 29% undervaluedOver the last 90 days, the stock has risen 1.3% to €0.0081. The fair value is estimated to be €0.011, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 29% over the last 3 years. Meanwhile, the company became loss making.New Risk • Dec 14New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.9m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.9m free cash flow). Share price has been highly volatile over the past 3 months (44% average weekly change). Earnings have declined by 34% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 18x increase in shares outstanding). Revenue is less than US$1m (AU$1.3m revenue, or US$814k). Market cap is less than US$10m (€3.23m market cap, or US$3.39m).Reported Earnings • Oct 24First half 2024 earnings releasedFirst half 2024 results: EPS: AU$0. Revenue: AU$276.1k (down 58% from 1H 2023). Net loss: AU$1.99m (loss widened 117% from 1H 2023). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Personal Products industry in the United Kingdom.Reported Earnings • May 01Full year 2023 earnings released: AU$0.001 loss per share (vs AU$18.64 loss in FY 2022)Full year 2023 results: AU$0.001 loss per share (improved from AU$18.64 loss in FY 2022). Revenue: AU$1.66m (down 44% from FY 2022). Net loss: AU$2.02m (loss narrowed 80% from FY 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Personal Products industry in the United Kingdom.New Risk • Apr 28New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (39% average weekly change). Earnings have declined by 60% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 39x increase in shares outstanding). Market cap is less than US$10m (€1.43m market cap, or US$1.53m). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Revenue is less than US$5m (AU$3.2m revenue, or US$2.1m).Board Change • Dec 21Less than half of directors are independentThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. 1 experienced director. 1 highly experienced director. 1 independent director (2 non-independent directors). Executive Chairman, CEO & MD Simon St. Ledger is the most experienced director on the board, commencing their role in 2012. Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.New Risk • Oct 18New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.0m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.0m free cash flow). Share price has been highly volatile over the past 3 months (89% average weekly change). Earnings have declined by 60% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 6x increase in shares outstanding). Market cap is less than US$10m (€482.9k market cap, or US$508.5k). Minor Risk Revenue is less than US$5m (AU$3.2m revenue, or US$2.1m).New Risk • Jun 29New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (52% average weekly change). Earnings have declined by 56% per year over the past 5 years. Shareholders have been substantially diluted in the past year (162% increase in shares outstanding). Market cap is less than US$10m (€374.5k market cap, or US$408.8k). Minor Risk Revenue is less than US$5m (AU$3.0m revenue, or US$2.0m).Reported Earnings • Jun 29Full year 2022 earnings released: AU$0.002 loss per share (vs AU$0.005 profit in FY 2021)Full year 2022 results: AU$0.002 loss per share (down from AU$0.005 profit in FY 2021). Revenue: AU$2.96m (down 1.5% from FY 2021). Net loss: AU$9.97m (down AU$10.2m from profit in FY 2021). Revenue is forecast to grow 7.9% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Personal Products industry in the United Kingdom.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Oct 05First half 2022 earnings released: EPS: AU$0.007 (vs AU$0.009 in 1H 2021)First half 2022 results: EPS: AU$0.007. Revenue: AU$1.99m (up 42% from 1H 2021). Net income: AU$1.07m (up 196% from 1H 2021). Profit margin: 54% (up from 26% in 1H 2021). The increase in margin was primarily driven by higher revenue. Revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Personal Products industry in the United Kingdom.Buying Opportunity • May 11Now 27% undervaluedOver the last 90 days, the stock is up 108%. The fair value is estimated to be €0.071, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.7% over the last 3 years. Meanwhile, the company became loss making.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Buying Opportunity • Mar 01Now 22% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be AU$0.066, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.7% per annum over the last 3 years. The company became loss making over the last 3 years.Board Change • Feb 01Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Dec 03Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Aug 31Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.株主還元0RNSGB Personal ProductsGB 市場7D92.4%-0.2%2.3%1Y0%-6.6%18.1%株主還元を見る業界別リターン: 0RNS過去 1 年間で-6.6 % の収益を上げたUK Personal Products業界を上回りました。リターン対市場: 0RNSは、過去 1 年間で18.1 % のリターンを上げたUK市場を下回りました。価格変動Is 0RNS's price volatile compared to industry and market?0RNS volatility0RNS Average Weekly Movement22.4%Personal Products Industry Average Movement5.5%Market Average Movement5.1%10% most volatile stocks in GB Market10.5%10% least volatile stocks in GB Market2.7%安定した株価: 0RNSの株価は、 UK市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 0RNSの 週次ボラティリティ は過去 1 年間で30%から22%に減少しましたが、依然としてUK株の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト20013Simon St. Ledgerwww.rnplc.comラピッドニュートリション社は、科学的根拠に基づいた健康食品を開発し、世界中に販売しているナチュラルヘルスケア企業である。System LSのブランド名で減量をサポートする天然成分やオーガニック成分を、Azureneのブランド名で喉の痛みや風邪、インフルエンザの症状に効く漢方薬、旅行者の免疫力を高めるアシュワガンダやアンドログラフィスを加えた製品を提供している。また、第三者ブランドの製品も提供している。ラピッドニュートリションPLCは2001年に設立され、イギリスのミルデンホールに本社を置いている。もっと見るRapid Nutrition PLC 基礎のまとめRapid Nutrition の収益と売上を時価総額と比較するとどうか。0RNS 基礎統計学時価総額€3.23m収益（TTM）-€1.90m売上高(TTM)€119.13k23.9xP/Sレシオ-1.5xPER（株価収益率0RNS は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計0RNS 損益計算書（TTM）収益AU$194.33k売上原価AU$141.40k売上総利益AU$52.93kその他の費用AU$3.15m収益-AU$3.10m直近の収益報告Dec 31, 2025次回決算日該当なし一株当たり利益（EPS）-6.53グロス・マージン27.24%純利益率-1,596.11%有利子負債／自己資本比率0.9%0RNS の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/28 19:32終値2026/07/28 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Rapid Nutrition PLC 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Longdley ZephirinZephirin Group, Inc.
お知らせ • 7hRapid Nutrition Rolls Out Premium Nutrition Pantry Across Healthshop+ Wellness Hub Network And Online ChannelsRapid Nutrition announced the expansion of its owned-brand portfolio through the rollout of its new Premium Nutrition Pantry across the HealthShop+ wellness hub network and online channels. The initial rollout of the Premium Nutrition Pantry will comprise up to 100 premium wholefood products featuring sustainably sourced, minimally processed ingredients designed to complement the Company's evidence-based nutrition philosophy and support healthier everyday living. The launch represents an important milestone in Rapid Nutrition's strategy to expand higher-margin owned-brand sales while leveraging its vertically integrated wellness platform to accelerate product innovation, improve commercial agility and support long-term growth. Historically, this category has generated annual sales approaching AUD 1 million across the Company's wellness hubs. Management believes introducing the Premium Nutrition Pantry under the Rapid Nutrition brand provides an opportunity to build upon this established consumer demand while strengthening brand ownership, increasing margin potential and supporting long-term shareholder value. The acquisition of the HealthShop+ wellness hub network has also provided Rapid Nutrition with access to valuable real-time customer purchasing data and category insights across multiple wellness hubs. As part of its broader digital transformation strategy, the Company is progressively incorporating AI-driven analytics to better understand customer purchasing behaviour, emerging wellness trends and evolving category demand. These insights are expected to support faster identification of high-potential product opportunities, optimise merchandising decisions and accelerate the expansion of both the Premium Nutrition Pantry and the Company's broader owned-brand portfolio across its wellness hubs and online channels. The launch of the Premium Nutrition Pantry represents the first commercial application of this strategy, demonstrating how proprietary customer data, AI-driven analytics and Rapid Nutrition's vertically integrated wellness platform can be combined to identify emerging category opportunities, accelerate product expansion and strengthen higher-margin owned-brand sales.
お知らせ • Jun 02Rapid Nutrition Expands Agentic AI Integration Across Consumer Wellness EcosystemRapid Nutrition PLC has progressively expanded the rollout of its technology-enabled engagement platform across investor communications, consumer wellness interactions and broader digital operations as part of its strategy to build a scalable HealthTech ecosystem at the intersection of nutrition, technology and consumer behaviour. Following the initial deployment across investor communications, Rapid Nutrition has observed improved accessibility and responsiveness, with investor enquiries increasingly being addressed in near real-time across multiple time zones. The Company has since expanded the platform across elements of its consumer ecosystem, including the Company’s flagship SystemLS brand, where early-stage engagement trends indicate increasing interaction with product, wellness and lifestyle-aligned content tailored to individual user interests and behaviours. Rapid Nutrition believes the application of artificial intelligence and agentic capabilities enables a transition from static information delivery toward more responsive, real-time and personalized engagement across both investor and consumer channels. The platform has been developed using Company materials and operational frameworks and continues to be refined by Rapid Nutrition’s experienced team to ensure alignment with the Company’s products, communication standards and broader wellness ecosystem.
お知らせ • May 13Rapid Nutrition plc Expands AI-Powered Agentic Platform to Consumer EcosystemRapid Nutrition PLC announced the expansion of its technology platform to its consumer-facing ecosystem, following a successful rollout within its investor communications infrastructure. The Company is extending these capabilities across its flagship SystemLS brand, enabling a more responsive and personalized approach to consumer health and wellness engagement. The platform delivers structured, on-demand guidance across nutrition, products, and lifestyle — available 24/7 in a private, confidential environment. As consumer expectations increasingly flavor personalized health solutions, the system is designed to translate product and nutritional information into practical, everyday guidance aligned to individual habits and routines. Trained on Company materials and informed by Rapid Nutrition’s experienced team, the platform ensures all responses reflect the Company’s product philosophy, nutritional methodologies, and established wellness programs. The system is designed to complement, not replace, professional human interaction — extending access to practitioner-informed guidance while maintaining alignment with the Company’s personalised nutrition approach. It supports consumer education only and does not constitute professional medical advice. This expansion represents a continued step in Rapid Nutrition’s strategy to deploy advanced technologies — including artificial intelligence and agentic capabilities — across both its corporate and consumer operations, driving deeper and more consistent engagement with long-term wellness programs.
Board Change • Apr 30Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. 1 independent director (2 non-independent directors). Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Apr 22Rapid Nutrition PLC (ENXTPA:ALRPD) agreed to acquire Health and wellness retail locations in Australia.Rapid Nutrition PLC (ENXTPA:ALRPD) agreed to acquire Health and wellness retail locations in Australia on April 20, 2026. The transaction is subject to consummation of due diligence investigation and final documentation.
Board Change • Feb 06Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. 1 independent director (2 non-independent directors). Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • 7hRapid Nutrition Rolls Out Premium Nutrition Pantry Across Healthshop+ Wellness Hub Network And Online ChannelsRapid Nutrition announced the expansion of its owned-brand portfolio through the rollout of its new Premium Nutrition Pantry across the HealthShop+ wellness hub network and online channels. The initial rollout of the Premium Nutrition Pantry will comprise up to 100 premium wholefood products featuring sustainably sourced, minimally processed ingredients designed to complement the Company's evidence-based nutrition philosophy and support healthier everyday living. The launch represents an important milestone in Rapid Nutrition's strategy to expand higher-margin owned-brand sales while leveraging its vertically integrated wellness platform to accelerate product innovation, improve commercial agility and support long-term growth. Historically, this category has generated annual sales approaching AUD 1 million across the Company's wellness hubs. Management believes introducing the Premium Nutrition Pantry under the Rapid Nutrition brand provides an opportunity to build upon this established consumer demand while strengthening brand ownership, increasing margin potential and supporting long-term shareholder value. The acquisition of the HealthShop+ wellness hub network has also provided Rapid Nutrition with access to valuable real-time customer purchasing data and category insights across multiple wellness hubs. As part of its broader digital transformation strategy, the Company is progressively incorporating AI-driven analytics to better understand customer purchasing behaviour, emerging wellness trends and evolving category demand. These insights are expected to support faster identification of high-potential product opportunities, optimise merchandising decisions and accelerate the expansion of both the Premium Nutrition Pantry and the Company's broader owned-brand portfolio across its wellness hubs and online channels. The launch of the Premium Nutrition Pantry represents the first commercial application of this strategy, demonstrating how proprietary customer data, AI-driven analytics and Rapid Nutrition's vertically integrated wellness platform can be combined to identify emerging category opportunities, accelerate product expansion and strengthen higher-margin owned-brand sales.
お知らせ • Jun 02Rapid Nutrition Expands Agentic AI Integration Across Consumer Wellness EcosystemRapid Nutrition PLC has progressively expanded the rollout of its technology-enabled engagement platform across investor communications, consumer wellness interactions and broader digital operations as part of its strategy to build a scalable HealthTech ecosystem at the intersection of nutrition, technology and consumer behaviour. Following the initial deployment across investor communications, Rapid Nutrition has observed improved accessibility and responsiveness, with investor enquiries increasingly being addressed in near real-time across multiple time zones. The Company has since expanded the platform across elements of its consumer ecosystem, including the Company’s flagship SystemLS brand, where early-stage engagement trends indicate increasing interaction with product, wellness and lifestyle-aligned content tailored to individual user interests and behaviours. Rapid Nutrition believes the application of artificial intelligence and agentic capabilities enables a transition from static information delivery toward more responsive, real-time and personalized engagement across both investor and consumer channels. The platform has been developed using Company materials and operational frameworks and continues to be refined by Rapid Nutrition’s experienced team to ensure alignment with the Company’s products, communication standards and broader wellness ecosystem.
お知らせ • May 13Rapid Nutrition plc Expands AI-Powered Agentic Platform to Consumer EcosystemRapid Nutrition PLC announced the expansion of its technology platform to its consumer-facing ecosystem, following a successful rollout within its investor communications infrastructure. The Company is extending these capabilities across its flagship SystemLS brand, enabling a more responsive and personalized approach to consumer health and wellness engagement. The platform delivers structured, on-demand guidance across nutrition, products, and lifestyle — available 24/7 in a private, confidential environment. As consumer expectations increasingly flavor personalized health solutions, the system is designed to translate product and nutritional information into practical, everyday guidance aligned to individual habits and routines. Trained on Company materials and informed by Rapid Nutrition’s experienced team, the platform ensures all responses reflect the Company’s product philosophy, nutritional methodologies, and established wellness programs. The system is designed to complement, not replace, professional human interaction — extending access to practitioner-informed guidance while maintaining alignment with the Company’s personalised nutrition approach. It supports consumer education only and does not constitute professional medical advice. This expansion represents a continued step in Rapid Nutrition’s strategy to deploy advanced technologies — including artificial intelligence and agentic capabilities — across both its corporate and consumer operations, driving deeper and more consistent engagement with long-term wellness programs.
Board Change • Apr 30Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. 1 independent director (2 non-independent directors). Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Apr 22Rapid Nutrition PLC (ENXTPA:ALRPD) agreed to acquire Health and wellness retail locations in Australia.Rapid Nutrition PLC (ENXTPA:ALRPD) agreed to acquire Health and wellness retail locations in Australia on April 20, 2026. The transaction is subject to consummation of due diligence investigation and final documentation.
Board Change • Feb 06Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. 1 independent director (2 non-independent directors). Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Buy Or Sell Opportunity • Jan 22Now 35,962% overvalued after recent price riseOver the last 90 days, the stock has risen 118,321% to €4.50. The fair value is estimated to be €0.012, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 41% over the last 3 years. Meanwhile, the company became loss making.
お知らせ • Jan 05Rapid Nutrition PLC announced that it has received €5 million in fundingRapid Nutrition PLC announced a private placement of common shares for gross proceeds of €5 million on January 5, 2026.
Reported Earnings • Oct 29First half 2025 earnings released: EPS: AU$0 (vs AU$0 in 1H 2024)First half 2025 results: EPS: AU$0 (in line with 1H 2024). Revenue: AU$113.1k (down 59% from 1H 2024). Net loss: AU$1.65m (loss narrowed 17% from 1H 2024). Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 2.7% growth forecast for the Personal Products industry in the United Kingdom.
New Risk • Oct 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 17% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 7x increase in shares outstanding). Revenue is less than US$1m (AU$917k revenue, or US$594k). Market cap is less than US$10m (€2.14m market cap, or US$2.50m). Minor Risks Latest financial reports are more than 6 months old (reported December 2024 fiscal period end). Share price has been volatile over the past 3 months (10% average weekly change).
Buy Or Sell Opportunity • Jun 20Now 29% undervaluedOver the last 90 days, the stock has risen 1.3% to €0.0081. The fair value is estimated to be €0.011, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 29% over the last 3 years. Meanwhile, the company became loss making.
New Risk • Dec 14New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.9m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.9m free cash flow). Share price has been highly volatile over the past 3 months (44% average weekly change). Earnings have declined by 34% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 18x increase in shares outstanding). Revenue is less than US$1m (AU$1.3m revenue, or US$814k). Market cap is less than US$10m (€3.23m market cap, or US$3.39m).
Reported Earnings • Oct 24First half 2024 earnings releasedFirst half 2024 results: EPS: AU$0. Revenue: AU$276.1k (down 58% from 1H 2023). Net loss: AU$1.99m (loss widened 117% from 1H 2023). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Personal Products industry in the United Kingdom.
Reported Earnings • May 01Full year 2023 earnings released: AU$0.001 loss per share (vs AU$18.64 loss in FY 2022)Full year 2023 results: AU$0.001 loss per share (improved from AU$18.64 loss in FY 2022). Revenue: AU$1.66m (down 44% from FY 2022). Net loss: AU$2.02m (loss narrowed 80% from FY 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Personal Products industry in the United Kingdom.
New Risk • Apr 28New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (39% average weekly change). Earnings have declined by 60% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 39x increase in shares outstanding). Market cap is less than US$10m (€1.43m market cap, or US$1.53m). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Revenue is less than US$5m (AU$3.2m revenue, or US$2.1m).
Board Change • Dec 21Less than half of directors are independentThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. 1 experienced director. 1 highly experienced director. 1 independent director (2 non-independent directors). Executive Chairman, CEO & MD Simon St. Ledger is the most experienced director on the board, commencing their role in 2012. Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.
New Risk • Oct 18New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.0m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.0m free cash flow). Share price has been highly volatile over the past 3 months (89% average weekly change). Earnings have declined by 60% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 6x increase in shares outstanding). Market cap is less than US$10m (€482.9k market cap, or US$508.5k). Minor Risk Revenue is less than US$5m (AU$3.2m revenue, or US$2.1m).
New Risk • Jun 29New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (52% average weekly change). Earnings have declined by 56% per year over the past 5 years. Shareholders have been substantially diluted in the past year (162% increase in shares outstanding). Market cap is less than US$10m (€374.5k market cap, or US$408.8k). Minor Risk Revenue is less than US$5m (AU$3.0m revenue, or US$2.0m).
Reported Earnings • Jun 29Full year 2022 earnings released: AU$0.002 loss per share (vs AU$0.005 profit in FY 2021)Full year 2022 results: AU$0.002 loss per share (down from AU$0.005 profit in FY 2021). Revenue: AU$2.96m (down 1.5% from FY 2021). Net loss: AU$9.97m (down AU$10.2m from profit in FY 2021). Revenue is forecast to grow 7.9% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Personal Products industry in the United Kingdom.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Oct 05First half 2022 earnings released: EPS: AU$0.007 (vs AU$0.009 in 1H 2021)First half 2022 results: EPS: AU$0.007. Revenue: AU$1.99m (up 42% from 1H 2021). Net income: AU$1.07m (up 196% from 1H 2021). Profit margin: 54% (up from 26% in 1H 2021). The increase in margin was primarily driven by higher revenue. Revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Personal Products industry in the United Kingdom.
Buying Opportunity • May 11Now 27% undervaluedOver the last 90 days, the stock is up 108%. The fair value is estimated to be €0.071, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.7% over the last 3 years. Meanwhile, the company became loss making.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Buying Opportunity • Mar 01Now 22% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be AU$0.066, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.7% per annum over the last 3 years. The company became loss making over the last 3 years.
Board Change • Feb 01Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Dec 03Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Aug 31Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Shayne Kellow was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
